2 Mg. Norethindrone-Mestranol in Contraception and Therapy
Francis, W.G.
Applied Therapeutics 6: 419-423
1964
ISSN/ISBN: 0570-4944 PMID: 14144492 Document Number: 479097
Document emailed within 1 workday
Related Documents
Dickinson, J.H.; Smith, G.G. 1963: A new and practical oral contraceptive agent: norethindrone with mestranol Canadian Medical Association Journal 89: 242-245Beer, M.A. 1964: Contraceptive Efficacy of Norethindrone with Mestranol: new low Dosage Form Journal of the Medical Society of New Jersey 61: 449-453
Martinez, O.B.; Roe, D.A. 1977: Lack of effect of norethindrone and mestranol on folacin depletion and repletion in rats Journal of Nutrition 107(7): 1157-1169
Tyler, E.T.; Olson, H.J.; Gotlib, M.; Levin, M.; Behne, D. 1964: Long Term Usage of Norethindrone with Mestranol Preparations in the Control of Human Fertility Clinical Medicine 71: 997-1024
De Sampaio Júnior, L.F.; Dib, J.E.; Pereira, V.M.; Neme, B. 1971: Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic Maternidade e Infancia; Arquivos Medicos-Sociais 30(1): 65-69
Laumas, V.; Malik, B.K.; Jamal, K.; Seth, U.; Agarwal, N.; Hingorani, V.; Laumas, K.R. 1978: Radioimmunoassay of norethindrone : serum levels of norethindrone in lactating women after insertion of a single Silastic implant releasing norethindrone acetate Contraception 18(6): 593-605
Tenhaeff, D.; Feldmann, H.U.; Rupek, R. 1972: Contraception with two low-dosage mestranol-norethisterone combinations Fortschritte der Medizin 90(12): 479-482
Goldzieher, J.W.; Moses, L.E.; Ellis, L.T. 1962: Study of norethindrone in contraception JAMA 180(5): 359-361
Carbia, E.; Rubio-Linares, G.; Alvarado-Duran, A.; Lopez-Llera, M. 1970: Histologic study of the uterine cervix during oral contraception with ethynodiol diacetate and mestranol Obstetrics and Gynecology 35(3): 381-388
Bhatnagar, S.; Srivastava, U.K.; Takkar, D.; Chandra, V.L.; Hingorani, V.; Laumas, K.R. 1975: Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women Contraception 11(5): 505-521
Wiese, J.; Marker, I.L.; Holma, P.; Vartiainen, E.; Osler, M.; Pyörälä, T.; Johansson, E.; Luukkainen, T. 1976: Long-term contraception with norethindrone subcutaneous capsules Annals of Clinical Research 8(2): 93-97
Shahani, S.M.; Kulkarni, P.P. 1982: Clinical evaluation of interval contraception by norethindrone acetate implant Indian Journal of Medical Research 76: 561-564
Gupta, G.N.; Saxena, B.B.; Landesman, R.; Ledger, W.J. 1984: Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study Fertility and Sterility 41(5): 726-731
1985: Phase II clinical study of implanted norethindrone pellets for long term contraception in women Advances in Contraception 1(4): 295-304
1985: Phase II clinical study of implanted norethindrone pellets for long term contraception in women Advances in Contraception 1(4): 295-304
Atrio, J.; Stek, A.; Vora, H.; Sanchez-Keeland, L.; Zannat, F.; Natavio, M. 2015: The effect of protease inhibitors on the cervical mucus of HIV-positive women taking norethindrone contraception European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 20(2): 149-153
Odlind, V.; Weiner, E.; Victor, A.; Johansson, E.D. 1979: Plasma levels of norethindrone after single oral dose administration of norethindrone and lynestrenol Clinical Endocrinology 10(1): 29-38
Odlind, V.; Weiner, E.; Johansson, E.D. 1979: Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone Contraception 19(2): 197-206
Takkar, D.; Anandalaxmi, P.N.; Chandra, V.L.; Bhatnagar, S.; Yadav, H.S.; Laumas, K.R.; Hingorani, V.; Krishna, U.; Mandleker, A.; Purandare, V.N.; Goel, V.; Adatia, A.; Virker, K.D. 1978: Long-term contraception by a single silastic implant-D containing norethindrone acetate in women: a clinical evaluation Contraception 17(4): 341-354
DuBois, B.N.; Atrio, J.; Stanczyk, F.Z.; Cherala, G. 2015: Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy Contraception 91(1): 71-75